LILA vs META

LILA exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and operational deterioration. The company is dangerously over-leveraged with a Debt/Equity ratio of 8.32, vastly exceeding the sector average of 0.90. While the stock has seen a 1-year price recovery and maintains a low Price/Sales ratio of 0.37, these are overshadowed by negative profit margins (-13.76%) and a disastrous ROE of -41.72%. The disconnect between the analyst 'Buy' recommendation and the deterministic health scores suggests a speculative bet on restructuring rather than a value-based investment.

META exhibits exceptional fundamental health with a Piotroski F-Score of 8/9, indicating strong financial strength across profitability, leverage, and operating efficiency. While the current price of $612.42 trades at a premium to the Graham Number ($213.17) and the growth-based Intrinsic Value ($542.14), the PEG ratio of 0.94 suggests the stock is undervalued relative to its high growth rate. Strong revenue growth (23.8%) and a low forward P/E (17.03) outweigh the bearish technical trend and insider selling. The company's dominant market position and consistent earnings beats support a bullish long-term outlook.